- Home
- MKFG vs GNTA Comparison
MKFG vs GNTA Comparison
Compare MKFG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKFG
- GNTA
- Stock Information
- Founded
- MKFG 2013
- GNTA 2014
- Country
- MKFG United States
- GNTA Italy
- Employees
- MKFG N/A
- GNTA N/A
- Industry
- MKFG Retail: Computer Software & Peripheral Equipment
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKFG Technology
- GNTA Health Care
- Exchange
- MKFG Nasdaq
- GNTA Nasdaq
- Market Cap
- MKFG 89.1M
- GNTA 96.9M
- IPO Year
- MKFG N/A
- GNTA 2021
- Fundamental
- Price
- MKFG $4.09
- GNTA $5.06
- Analyst Decision
- MKFG Hold
- GNTA Strong Buy
- Analyst Count
- MKFG 2
- GNTA 1
- Target Price
- MKFG $5.00
- GNTA $25.00
- AVG Volume (30 Days)
- MKFG 124.3K
- GNTA 8.6K
- Earning Date
- MKFG 11-07-2024
- GNTA 01-01-0001
- Dividend Yield
- MKFG N/A
- GNTA N/A
- EPS Growth
- MKFG N/A
- GNTA N/A
- EPS
- MKFG N/A
- GNTA N/A
- Revenue
- MKFG $86,889,000.00
- GNTA N/A
- Revenue This Year
- MKFG N/A
- GNTA N/A
- Revenue Next Year
- MKFG $9.20
- GNTA N/A
- P/E Ratio
- MKFG N/A
- GNTA N/A
- Revenue Growth
- MKFG N/A
- GNTA N/A
- 52 Week Low
- MKFG $1.57
- GNTA $2.20
- 52 Week High
- MKFG $8.90
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- MKFG 34.24
- GNTA 50.84
- Support Level
- MKFG $4.35
- GNTA $4.61
- Resistance Level
- MKFG $4.51
- GNTA $5.44
- Average True Range (ATR)
- MKFG 0.07
- GNTA 0.46
- MACD
- MKFG -0.07
- GNTA -0.05
- Stochastic Oscillator
- MKFG 8.33
- GNTA 56.54
About MKFG Markforged Holding Corporation
Markforged Holding Corp transforms manufacturing with 3D metal and continuous carbon fiber printers capable of producing parts tough enough for the factory floor. intuitive additive manufacturing platform for modern manufacturers, bringing the power and speed of agile software development to industrial manufacturing. Composed of hardware, software and materials working as a unified platform. It operates in industries such as Aerospace, Automotive, Consumer Packaged Goods, Education and Research, Electronics Manufacturing, Energy, Federal and Defense, Industrial Equipment. The company's geographical segments include the Americas; Europe, the Middle East, Africa; and Asia-Pacific. It derives maximum revenue from Americas.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.